Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
about
Data on the utilization of treatment modalities for ED in Taiwan in the era of PDE5 inhibitors.Substandard drugs: a potential crisis for public health.A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010Microbiological contamination in counterfeit and unapproved drugs.Quality of online pharmacies and websites selling prescription drugs: a systematic reviewCounterfeit drug penetration into global legitimate medicine supply chains: a global assessmentPhosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction.Assessing the problem of counterfeit medications in the United Kingdom.Mass spectrometric analysis of pharmaceutical adulterants in products labeled as botanical dietary supplements or herbal remedies: a review.InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.Adulterated and Counterfeit Male Enhancement Nutraceuticals and Dietary Supplements Pose a Real Threat to the Management of Erectile Dysfunction: A Global Perspective.The dangers of sexual enhancement supplements and counterfeit drugs to "treat" erectile dysfunction.Counterfeit dapoxetine sold on the Internet contains undisclosed sildenafil.Hospital Audit as a Useful Tool in the Process of Introducing Falsified Medicines Directive (FMD) into Hospital Pharmacy Settings-A Pilot Study.Collision-induced dissociation pathways of H1-antihistamines by electrospray ionization quadrupole time-of-flight mass spectrometry.A detailed analysis of online pharmacy characteristics to inform safe usage by patients.Isolation and structural elucidation of a new tadalafil analogue in health supplements: bisprenortadalafil.Consumers Turning to the Internet Pharmacy Market: Cross-Sectional Study on the Frequency and Attitudes of Hungarian Patients Purchasing Medications Online
P2860
Q30739538-FDFA7F5E-52DA-4558-9622-4EA4A58B4F1DQ34065256-7D59081F-7822-4391-9231-7BD8A613254AQ35110415-DACF747B-61BB-4663-B0B8-3777DDAD1370Q35195014-9EC66FF9-F95A-4F52-8DD2-5FA9318A174AQ35567701-71802503-45D7-41FE-98C8-B5B59C0DBE4EQ35681817-9770448D-ECDE-4FD6-933E-95D98851E7A5Q37733556-DCA970FE-8478-42CC-8CD7-0995F09E6346Q37954383-883F64BB-D8F8-4B77-A6AD-756604E81DBBQ38255743-EEE487EA-5A93-4472-B151-47F501B655C3Q38705389-5A680D1A-7165-4616-A818-CFD0B2CFF889Q38749357-FD8894D6-BD87-462C-8501-72EF28DD5206Q39143822-2FAF9AD5-1863-493E-8FD0-84E2662E371CQ43055644-4A1A1307-D75C-42DF-8062-B9B740C7E32CQ47164546-5DEF0657-AA56-4035-9807-D62F34748921Q48295900-E83B0E6E-F734-4D33-8514-DA7B96064719Q49939839-5B44810E-B10E-4000-A397-00DE8244767AQ54374606-E8FC8264-50B4-4BA1-A1CE-45EC471E783AQ57168030-BC5F07E5-D90B-4F8E-8620-B207E3B46230
P2860
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@ast
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@en
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@nl
type
label
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@ast
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@en
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@nl
prefLabel
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@ast
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@en
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@nl
P2093
P2860
P921
P1476
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
@en
P2093
P2860
P304
P356
10.1111/J.1742-1241.2009.02328.X
P50
P5008
P577
2010-01-18T00:00:00Z